Decision-Making in Critical Limb Ischemia: A Markov Simulation.

Area of Science:

• Vascular Surgery
• Decision Modeling
• Health Economics

Background:

• Critical limb ischemia (CLI) is a severe complication of peripheral vascular disease.
• Management often involves complex decisions for patients with comorbidities like heart failure and diabetes.
• A decision model was created to evaluate treatment strategies for a specific patient profile.

Observation:

• A Markov decision model compared amputation, surgical bypass, endovascular therapy, and medical management.
• Sensitivity analyses were performed to assess the impact of parameter uncertainty.
• Quality-adjusted life months (QALMs) were used as the primary outcome measure.

Findings:

• Endovascular therapy and surgical bypass demonstrated comparable effectiveness in the base case (26.50 vs. 26.34 QALMs).
• Both revascularization strategies significantly outperformed amputation (18.83 QALMs) and medical management (11.08 QALMs).
• Results remained robust across various mortality and utility weight scenarios, though long-term mortality was a key sensitivity factor.

Implications:

• Endovascular therapy and surgical bypass are viable, comparable options for CLI management.
• The choice between endovascular and surgical approaches should consider procedure-specific long-term mortality.
• Both advanced revascularization techniques offer superior outcomes compared to amputation or conservative medical treatment for CLI patients.